Profile data is unavailable for this security.
About the company
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by leveraging the technology in personalized medicine for improved patient diagnosis and management. It has five commercialized molecular tests and one test in a clinical evaluation program: PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR v2, RespriDX, and BarreGEN. PancraGEN is for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts. PanDNA is a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors. ThyGeNEXT is for the diagnosis of thyroid cancer from thyroid nodules. RespriDX differentiates lung cancer of primary versus metastatic origin.
- Revenue in USD (TTM)40.21m
- Net income in USD1.11m
- Incorporated1998
- Employees108.00
- LocationInterpace Biosciences IncWaterview PlazaSuite 310, 2001 Route 46PARSIPPANY 07054United StatesUSA
- Phone+1 (412) 224-6100
- Fax+1 (302) 636-5454
- Websitehttps://www.interpace.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Greenbrook TMS Inc | 80.08m | -68.03m | 3.83m | 629.00 | -- | -- | -- | 0.0478 | -2.21 | -2.21 | 2.48 | -1.06 | 1.07 | -- | 6.67 | 127,319.30 | -91.88 | -51.23 | -176.23 | -74.15 | 44.96 | 45.93 | -85.75 | -62.45 | -- | -2.29 | 1.72 | -- | 32.39 | 38.06 | -149.38 | -- | -22.47 | -- |
| IMAC Holdings Inc | 0.00 | -6.48m | 4.23m | 2.00 | -- | -- | -- | -- | -5.82 | -8.47 | 0.00 | -0.6554 | 0.00 | -- | -- | 0.00 | -105.93 | -48.88 | -332.19 | -70.25 | -- | -- | -- | -97.63 | -- | -30.07 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
| Dror Ortho-Design Inc | 0.00 | -3.57m | 4.26m | 4.00 | -- | 1.35 | -- | -- | -0.0091 | -0.0091 | 0.00 | 0.0064 | 0.00 | -- | -- | -- | -202.45 | -140.50 | -292.06 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Rennova Health Inc | 20.30m | 2.38m | 4.31m | 85.00 | 10.00 | -- | 1.57 | 0.212 | 0.00001 | 0.00001 | 0.00008 | -0.0007 | 1.01 | 27.77 | 7.93 | 238,855.30 | 11.79 | -116.33 | -- | -- | 63.10 | 7.22 | 11.66 | -159.89 | 0.1147 | 1.86 | -- | -- | 304.36 | 33.38 | 34.70 | -- | -52.27 | -- |
| Assure Holdings Corp | 255.00k | -21.45m | 4.44m | 95.00 | -- | -- | -- | 17.43 | -3.80 | -4.60 | 0.055 | -2.28 | 0.0161 | -- | 0.0272 | 2,684.21 | -135.04 | -35.15 | -937.78 | -46.37 | -860.39 | 37.14 | -8,410.59 | -116.06 | -- | -5.92 | -- | -- | -45.86 | -55.62 | 6.19 | -- | -- | -- |
| OpGen Inc | 3.07m | -26.16m | 5.16m | 100.00 | -- | 1.53 | -- | 1.68 | -6.51 | -6.51 | 0.55 | 0.2673 | 0.1202 | 2.91 | 5.64 | 30,702.30 | -102.41 | -79.05 | -196.63 | -110.12 | 6.62 | 22.60 | -852.12 | -706.29 | 0.1809 | -7.53 | 0.7746 | -- | -39.45 | -4.08 | 11.17 | -- | 16.36 | -- |
| Interpace Biosciences Inc | 40.21m | 1.11m | 5.95m | 108.00 | 5.45 | -- | 2.78 | 0.148 | 0.2495 | 0.1769 | 9.21 | -3.48 | 2.77 | 13.31 | 8.03 | 372,342.60 | 7.67 | -38.19 | -- | -69.73 | 59.44 | 49.44 | 2.77 | -41.01 | 0.5205 | 2.78 | -- | -- | 26.31 | 12.93 | 118.96 | -- | 0.9184 | -- |
| Selectis Health Inc | 36.78m | -4.00m | 6.13m | 574.00 | -- | -- | -- | 0.1668 | -1.31 | -1.31 | 12.04 | -0.9663 | 0.8846 | -- | 14.72 | 64,081.97 | -9.55 | -3.03 | -13.65 | -3.58 | -- | -- | -10.80 | -4.84 | -- | -4.12 | 1.09 | -- | -9.40 | 58.97 | -64.93 | -- | -47.72 | -- |
| Mangoceuticals Inc | 731.49k | -9.21m | 6.26m | -- | -- | 7.33 | -- | 8.56 | -0.6158 | -0.6158 | 0.0467 | 0.0362 | 0.7122 | -- | -- | -- | -896.99 | -- | -1,164.35 | -- | 58.99 | -- | -1,259.41 | -- | 3.79 | -- | 0.00 | -- | 8,082.22 | -- | -361.07 | -- | -- | -- |
| Biocorrx Inc | 89.17k | -3.77m | 6.61m | 5.00 | -- | -- | -- | 74.15 | -0.4532 | -0.4532 | 0.0107 | -1.13 | 0.1543 | -- | 0.7353 | -- | -652.63 | -291.68 | -- | -- | 59.64 | 67.13 | -4,228.44 | -3,208.40 | -- | -4.22 | -- | -- | -58.31 | -25.04 | 13.79 | -- | -- | -- |
| Syra Health Corp | 5.52m | -2.94m | 6.88m | 78.00 | -- | 1.67 | -- | 1.25 | -0.5034 | -0.5034 | 0.9726 | 0.625 | -- | -- | -- | 70,706.92 | -- | -- | -- | -- | 25.60 | -- | -53.28 | -- | -- | -56.90 | 0.044 | -- | -1.83 | -- | -38.72 | -- | -- | -- |
